Trade Report: The ICU Medical Inc. (ICUI) Director Richard Md Sherman Sold 1,500 Shares

The ICU Medical Inc. (ICUI) Director Richard Md Sherman Sold 1,500 Shares

ICU Medical Inc. (NASDAQ:ICUI) Director Richard Md Sherman sold 1,500 shares of the stock in a transaction that occurred on Thursday, October 6th. The shares were sold at an average price of $140.60, for a total transaction of $210,900.00. Following the completion of the transaction, the director now directly owns 70,699 shares of the company’s stock, valued at $9,940,279.40. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Richard Md Sherman also recently made the following trade(s): On Monday, September 19th, Richard Md Sherman sold 3,000 shares of ICU Medical stock. The stock was sold at an average price of $122.51, for a total transaction of $367,530.00.

Shares of ICU Medical Inc. (NASDAQ:ICUI) opened at 149.65 on Friday. The firm has a market cap of $2.41 billion, a PE ratio of 44.57 and a beta of 0.37. The stock’s 50 day moving average is $126.14 and its 200-day moving average is $112.44. ICU Medical Inc. has a 52 week low of $85.56 and a 52 week high of $150.37.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings data on Monday, August 8th. The company reported $1.15 EPS for the quarter, topping the Zacks’ consensus estimate of $1.05 by $0.10. ICU Medical had a return on equity of 10.33% and a net margin of 14.94%. The business earned $96.70 million during the quarter, compared to the consensus estimate of $89.66 million. During the same period in the previous year, the company posted $0.97 earnings per share. The business’s revenue for the quarter was up 15.4% on a year-over-year basis. On average, equities analysts predict that ICU Medical Inc. will post $4.54 EPS for the current fiscal year.

ICUI has been the topic of several research reports. Zacks Investment Research upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $140.00 price target on the stock in a report on Friday, August 12th. Piper Jaffray Cos. reiterated a “neutral” rating and issued a $119.00 price target (up previously from $115.00) on shares of ICU Medical in a report on Thursday, August 11th.

Several institutional investors have recently made changes to their positions in the company. Tower Research Capital LLC TRC bought a new position in shares of ICU Medical during the second quarter worth approximately $124,000. Bank of Montreal Can acquired a new stake in ICU Medical during the second quarter valued at $133,000. PineBridge Investments L.P. boosted its stake in ICU Medical by 3.6% in the second quarter. PineBridge Investments L.P. now owns 1,835 shares of the company’s stock valued at $207,000 after buying an additional 63 shares during the last quarter. Amalgamated Bank acquired a new stake in ICU Medical during the second quarter valued at $214,000. Finally, M&T Bank Corp boosted its stake in ICU Medical by 3.3% in the first quarter. M&T Bank Corp now owns 2,117 shares of the company’s stock valued at $220,000 after buying an additional 67 shares during the last quarter. 89.50% of the stock is owned by institutional investors and hedge funds.

ICU Medical Company Profile

Related posts

Leave a Comment